Lion Street Advisors, LLC Danaher Corp Transaction History

Lion Street Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	BUY	$224.99 - $256.14 $228,139 - $259,725	1,014 New	1,014 $243,000
Q4 2022 Jan 19, 2023	BUY	$241.42 - $282.29 $233,694 - $273,256	968 New	968 $0
Q2 2022 Jul 19, 2022	BUY	$237.11 - $299.66 $229,522 - $290,070	968 New	968 $301,000
Q1 2022 May 10, 2022	SELL	$257.27 - $315.76 $233,601 - $286,710	-908 Closed	0 $0
Q4 2021 Jan 20, 2022	SELL	$292.08 - $329.01 $17,524 - $19,740	-60 Reduced 6.2%	908 $301,000
Q3 2021 Nov 15, 2021	BUY	$272.21 - $332.43 $263,499 - $321,792	968 New	968 $292,000
Q2 2020 Jul 20, 2020	SELL	$128.7 - $176.83 $23,037 - $31,652	-179 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$121.39 - $169.05 $21,728 - $30,259	179 New	179 $25,000

2,507

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Lion Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lion Street Advisors, LLC with notifications on news.